Get the tools used by (smart)2 investors.
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Cash from Operations

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

-
Price
–
Fair Value
–
Upside
- - -
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on 's Cash from Operations:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 2024500 M1 B1.5 B2 B
Performance Summary
  • Edwards Lifesciences's latest twelve months cash from operations is 542.3 million
  • Edwards Lifesciences's cash from operations for fiscal years ending December 2020 to 2024 averaged 1.089 billion.
  • Edwards Lifesciences's operated at median cash from operations of 1.054 billion from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Edwards Lifesciences's cash from operations peaked in December 2021 at 1.732 billion.
  • Edwards Lifesciences's cash from operations hit its 5-year low in December 2024 of 542.3 million.
  • Edwards Lifesciences's cash from operations decreased in 2020 (1.054 billion, -10.9%), 2022 (1.218 billion, -29.7%), 2023 (895.8 million, -26.5%), and 2024 (542.3 million, -39.5%) and increased in 2021 (1.732 billion, +64.3%).

How does Edwards Lifesciences's Cash from Operations benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Edwards Lifesciences Corp because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Edwards Lifesciences Cash from Operations Benchmarks
NameTickerCash from Operations
AngioDynamics IncNASDAQGS:ANGO-23.305 M
Nevro CorpNYSE:NVRO-19.439 M
Neuropace IncNASDAQGM:NPCE-17.949 M
HealthcareSECTOR:HLTH.US-12.464 M
AtriCure IncNASDAQGM:ATRC12.204 M
Artivion IncNYSE:AORT22.236 M
Haemonetics CorporationNYSE:HAE129.2 M
Penumbra IncNYSE:PEN168.5 M
ICU Medical IncNASDAQGS:ICUI204 M
Integer Holdings CorpNYSE:ITGR205.2 M
Merit Medical Systems IncNASDAQGS:MMSI220.8 M
Edwards Lifesciences CorpNYSE:EW542.3 M

Metric Usage: Cash from Operations

Hide this widget
cash_from_operations
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Cash from Operations in the financials category include:

  • Restatement Type - This item represents if the data for a period is based on the latest Press Release or Original filing
  • Capital Expenditures - The overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
  • Long-term Operating Lease Liabilities -
  • Normalized Net Income - This item is EBT, Excl. Unusual Items * (1 - Statutory Tax Rate) + Minority Int. in Earnings. Note: this metric assumes a statutory tax rate of 37.5% for all companies.
View Full List

Search for metric or datapoint

Cash from Operations

Represents the amount of cash generated or consumed by a company's core business operations

Definition of Cash from Operations

Hide this widget

_invpro_glossary_calculation_undefined_year

The tables below summarizes Edwards Lifesciences’s Cash from Operations and common size over the last five years:

Fiscal YearCash from Operations
2020-12-311.054 B
2021-12-311.732 B
2022-12-311.218 B
2023-12-31895.8 M
2024-12-31542.3 M

The tables below summarizes Edwards Lifesciences’s Cash from Operations and common size over the last four quarters:

Quarter EndingCash from Operations
2024-03-31-53.5 M
2024-06-30371.5 M
2024-09-30351.8 M
2024-12-31-127.5 M
Click the link below to download a spreadsheet with an example Cash from Operations calculation for Edwards Lifesciences Corp below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-61.273 M-31.273 M-1.273 M43.109 M0200400

The chart above depicts the distribution of cash from operations for companies operating in the Healthcare sector in the Developed economic region. Over 3,175 companies were considered in this analysis, and 1,947 had meaningful values. The average cash from operations of companies in the sector is -8.12 M with a standard deviation of 17.335 M.

Edwards Lifesciences Corp's Cash from Operations of 542.3 M is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:

Cash from Operations In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents3,180
Included Constituents1,947
Min-58.788 M
Max40.624 M
Median-3.522 M
Mean-8.12 M
Standard Deviation17.335 M

You can find companies with similar cash from operations using this stock screener.

All rights reserved. Terms Of Use